Ethical Risk Monitoring & Dual-Use Gating
Comprehensive ethical governance framework ensuring all ABI operations maintain defensive-only posture, evidence-first methodology, and continuous monitoring for dual-use risk, proportionality, equity, and human rights compliance.
Six Pillars of Ethical Governance
Every ABI service, analytic pathway, and operational output is governed by six non-negotiable ethical pillars. These are not aspirational — they are enforced through automated gating, audit trails, and fail-closed discipline.
Defensive-Only Posture
ABI operates under a strictly defensive-only posture. No offensive, weaponization, or dual-use enabling outputs are generated, stored, or transmitted. Every service, analytic branch, and emission is gated against offensive potential before release.
Automated dual-use screening at intake, synthesis, and emission stages. Fail-closed embargo on any output flagged for offensive potential.
Transparency & Explainability
All analytic reasoning, scenario branches, evidence classifications, and confidence intervals are fully transparent and auditable. No black-box outputs. Every decision path is traceable from input to emission.
Helios audit spine records all reasoning artifacts. Evidence class labels ([FACT], [INFERRED], [UNKNOWN], [WITHHELD ON GAP]) are mandatory on all outputs.
Human-in-the-Loop Governance
Critical decisions, escalations, and high-impact emissions require human review and authorization. The system augments human judgment — it does not replace it. Autonomous action is bounded by pre-defined safety envelopes.
Mandatory human review gates for crisis-level outputs, dual-use flagged content, and cross-jurisdictional escalations.
Proportionality & Non-Harm
All recommendations, scenario branches, and operational guidance are assessed for proportionality. Disproportionate responses, collateral harm potential, and unintended consequences are flagged and mitigated.
Proportionality scoring integrated into scenario synthesis. Disproportionate branches flagged for Contradiction Resolver review.
Privacy & Data Sovereignty
Personal health information, genomic data, and cross-jurisdictional sensitive data are protected by differential privacy overlays, GDPR/HIPAA compliance gating, and data sovereignty enforcement.
Automated PHI detection, differential privacy application, and jurisdictional data residency enforcement at all processing stages.
Equity & Non-Discrimination
All services, recommendations, and resource allocation guidance are assessed for equity impacts. Algorithmic bias detection and mitigation are integrated into AI/ML governance workflows.
Bias detection modules in all AI-driven analytics. Equity impact assessment mandatory for resource allocation and policy recommendations.
Four-Stage Dual-Use Gating Pipeline
Every data flow, analytic branch, and output passes through a four-stage dual-use gating pipeline. At each stage, potential offensive application is screened, flagged, and blocked with fail-closed discipline.
Intake Screening
Flag → Embargo → EscalateAll incoming requests, data feeds, and research queries are screened against dual-use risk indicators. Requests with potential offensive application are flagged, embargoed, and escalated.
Synthesis Gating
Isolate → Tag → BlockDuring multi-branch scenario decomposition, any branch that could enable offensive capability, weaponization, or proliferation is isolated, tagged, and blocked from further synthesis.
Emission Control
Screen → Withhold → Human ReviewFinal outputs are screened against comprehensive dual-use taxonomies before release. Outputs with residual dual-use risk are withheld and routed to human review.
Post-Emission Audit
Monitor → Review → RecallAll released outputs are continuously monitored for downstream dual-use application. Anomalous usage patterns trigger retrospective review and potential recall.
Dual-Use Risk Matrix
Comprehensive risk assessment across all technology domains with likelihood, impact, and mitigation mapping.
| DOMAIN | RISK | LIKELIHOOD | IMPACT | MITIGATION |
|---|---|---|---|---|
| Gene Editing / CRISPR | HIGH | Moderate | Severe | Automated screening of all gene editing queries, dual-use abstraction enforcement, gain-of-function research monitoring |
| Synthetic Biology | HIGH | Moderate | Severe | Synthetic construct risk assessment, biosafety compliance gating, institutional review board alignment |
| AI-Augmented Pathogen Design | CRITICAL | Low-Moderate | Catastrophic | Complete emission embargo on pathogen design queries, red team adversarial testing, law enforcement notification protocols |
| Quantum Decryption | HIGH | Low | Severe | PQC migration enforcement, cryptographic agility monitoring, classified data protection protocols |
| Autonomous Laboratory Systems | MODERATE | Moderate | Moderate | Laboratory automation governance, process integrity monitoring, human-in-the-loop requirements |
| Nanomaterials & Advanced Materials | MODERATE | Low | Moderate | Materials risk assessment, environmental impact monitoring, regulatory compliance tracking |
Scenario-Specific Ethical Matrices
Pandemic Pathogen Emergence
Balancing rapid response with data privacy, equitable resource allocation, and avoiding panic-inducing communications
PHI protection overlays, equity impact assessment, proportionality scoring on containment recommendations
Dual-Use Research Discovery
Managing disclosure of dual-use potential without enabling misuse, while maintaining scientific transparency
Immediate embargo, institutional review board notification, law enforcement coordination, controlled disclosure protocols
AI-Driven Bioweapon Threat
Responding to AI-augmented biological threats without revealing defensive vulnerabilities or enabling adversary adaptation
Classified response protocols, need-to-know information partitioning, adversarial simulation before public disclosure
Cross-Border Data Sharing Crisis
Enabling international cooperation while respecting data sovereignty, privacy laws, and national security constraints
Jurisdictional compliance mapping, differential privacy enforcement, bilateral data sharing agreement verification
Ethical Performance Metrics
Dual-Use Flag Rate
< 0.1% of total queriesPercentage of incoming queries flagged for potential dual-use application
Embargo Activation Rate
100% on flagged itemsPercentage of dual-use flagged items successfully embargoed before emission
Human Review Completion
< 4 hours for HIGH riskTime to complete human review of escalated dual-use flagged items
False Positive Rate
< 5% of flagsPercentage of dual-use flags determined to be false positives after review
Post-Emission Anomaly Detection
< 24 hoursTime to detect anomalous downstream usage of released outputs
Ethical Review Board Response
< 48 hoursTime for ethical review board to respond to escalated ethical concerns
Review Full Governance Architecture
Explore ABI's comprehensive compliance, audit, and ethical governance frameworks.